Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype
Volume 11, Issue 1, December 2022 .
Source: OncoImmunology - Category: Cancer & Oncology Authors: Sandra van Wilpe Donjet ë Simnica Peter Slootbeek Thomas van Ee Samhita Pamidimarri Naga Mark A. J. Gorris Lieke L. van der Woude Shabaz Sultan Rutger H. T. Koornstra Inge M. van Oort Winald R. Gerritsen Leonie I. Kroeze Michiel Simons Geert J. L. H. van Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Gastroschisis Repair | Prostate Cancer